Eli Lilly and Company

États‑Unis d’Amérique


 
Quantité totale PI 3 606
Quantité totale incluant filiales 3 817 (+ 211 pour les filiales)
Rang # Quantité totale PI 308
Note d'activité PI 4/5.0    2 483
Rang # Activité PI 269
Activité incl filiales 3,7/5.0    2 514
Symbole boursier
ISIN US5324571083
Capitalisation 137,300M  (USD)
Industrie Drug Manufacturers - Major
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

691 594
372 240
989 3
717
 
Dernier brevet 2024 - Systems and methods for detectin...
Premier brevet 1897 - Process for preparing lysergic a...
Dernière marque 2024 - PALJURNI
Première marque 1915 - PULVULES

Filiales

19 subsidiaries with IP (140 patents, 71 trademarks)

15 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, A...
P/S Providing medical information; providing medical information in the field of Alzheimer's.
P/S Medical information services, namely providing information related to healthcare and diseases and...
P/S Downloadable software in the nature of a mobile application for providing healthcare-related info...
P/S Educational services on the topic of medical matters; arranging and conducting educational forums...
P/S Medical information services in the field of pharmaceuticals and clinical trials; providing data ...
P/S Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention an...
P/S Scientific research and development; Scientific laboratory services, namely, providing shared wet...
P/S Providing medical information; providing medical information in the field of Alzheimer's
P/S Near field communication (NFC) tags for the purpose of tracking and authenticating pharmaceutical...
P/S Medical information services in the field of diabetes, endocrine diseases and disorders, metaboli...
P/S Medical information services in the field of diabetes, obesity, overweight and metabolic disease;...
P/S Printed reports featuring laboratory, clinical and diagnostic testing and results; printed inform...
P/S Medical information services in the field of diabetes
P/S Providing medical and scientific research information including in the field of Alzheimer's and r...
P/S Providing medical and scientific research information in the field of Alzheimer's and related dis...
P/S Educational services, namely, programs for healthcare personnel about clinical cases and communic...
2023 Invention Medication delivery device including disposable and reusable portions. A medication delivery dev...
Invention Medication delivery device with a sensed element. A medication delivery device including a devic...
Invention Kcnq potentiators. Small molecule potentiatiors to potassium channels (such as Kv7 potentiators—...
Invention Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-pipe...
Invention Methods for producing fabs and igg bispecific antibodies. Methods for producing Fabs and IgG bi-...
Invention Anti-human lair1 antibodies. The present disclosure relates to antibodies that bind human LAIR1 (...
Invention Treatment and prevention of diseases. Methods of modulating expression and / or secretion of at l...
Invention Systems and methods for detecting state of a medication delivery device. A sensing system for det...
Invention Gip and glp-1 dual agonist compounds. The present invention relates to a pharmaceutical compositi...
Invention A gip/glp1 for use in therapy. The present invention provides a method for improving glycemic con...
Invention Glucocorticoid receptor agonists. The present invention provides a compound of Formula I: The ...
Invention Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives as fgfr3 inhibitors for the treatm...
Invention Co-crystals of 4-[4-[3-chloro-4-[1-(2-pyridyl)-2-hydroxy-ethoxy]pyrazolo[1,5-a]pyridin-6-yl]-5-me...
Invention Infusion site failure detection. Systems, methods, and devices are provided for predicting a stat...
Invention Compositions for oral delivery. The present invention relates to a dosage form suitable for oral ...
Invention Pd-1 agonist antibodies and methods of treating autoimmune diseases with a pd-1 agonist antibody....
Invention Sstr4 agonist salts. The present invention relates to specific salts of (1S,5R)-(1α,5α,6α)-N-[1,...
Invention Transferrin receptor binding proteins and conjugates. Provided herein are proteins comprising on...
Invention Transferrin receptor binding proteins and conjugates. Provided herein are proteins comprising one...
Invention Pharmaceutical solutions of anti-n3pglu aβ antibodies and uses thereof. The present disclosure re...
Invention Kras g12c inhibitor for treating cancer. Disclosed herein are dosing regimens for the administrat...
Invention Tirzepatide compositions and use. A composition and methods of dosing such tirzepatide compositio...
Invention Human cd33 antibodies and glucocorticoid conjugates. The present disclosure provides human CD33 a...
Invention Atxn2 rna interference agents. Provided herein are ATXN2 RNAi agents and compositions comprising ...
Invention Fluid delivery cassette. A fluid delivery cassette includes a cartridge assembly and a needle ass...
Invention Cgas inhibitors. The present invention relates to novel cGAS inhibitor compounds, to pharmaceuti...
Invention Cgas inhibitors. The present invention relates to novel cGAS inhibitor compounds, to pharmaceutic...
Invention Methods of using a gcg/glp1 co-agonist for therapy. Doses and dosing regimens for incretin analog...
Invention Human interleukin-4 receptor alpha antibody glucocorticoid conjugates. The present disclosure pro...
Invention Lasofoxifene combination treatment of er+ breast cancer that has progressed on a cdk4/6 inhibitor...
Invention Continuous tangential flow filtration system. Tangential flow filtration systems and, more specif...
Invention Human tumor necrosis factor alpha antibody glucocorticoid conjugates. The present disclosure pro...
Invention Kras inhibitors. The present invention provides compounds of the formula: The present inventio...
2022 Invention Techniques for processing wirelessly broadcast packets from a medical device with dose-related da...
Invention Automatic injection device
Invention Status sensing systems for connected injection device. Drug-delivery systems configured to gener...
Invention Oxyntomodulin binding molecules, and uses thereof. Provided herein are novel N- and C-terminal o...
Invention Anti-n3pglu amyloid beta antibodies and uses thereof. The invention is directed to treatment or ...
Invention Hub for reusable drug-delivery device. A recharging and medication storage hub for a re-usable d...
2021 Invention Pretargeting imaging agents. The present invention provides novel compounds: The present inven...
Invention Methods of treating diabetes. Described herein are fixed doses and dosing regimens for long-acti...
Invention Methods of treating diabetes. Described herein are doses and dosing regimens comprising determin...
Invention Fluid delivery system with needle assembly. A needle assembly configured to be part of a drug de...
Invention Kras g12c inhibitors. The present disclosure provides compounds of the formula: The present di...
Invention Medication delivery device with moisture sensing system. Medication delivery devices are provide...
Invention Methods for reducing host cell protein content in antibody purification processes and antibody co...
Invention Devices and processes for delivery of therapeutic fluids. A therapeutic agent delivery system in...
2020 Invention Medication delivery device with needle carrier. Drug delivery devices are provided having a need...